MedPath

The Effects of Exogenous Ketosis on Ultra-endurance Recovery and Performance

Not Applicable
Recruiting
Conditions
Exogenous Ketosis
Endurance Cycling Performance
Fatigue; Muscle, Heart
Fatigue, Mental
Registration Number
NCT06965491
Lead Sponsor
KU Leuven
Brief Summary

The study aims to investigate the effects of post-exercise and pre-sleep ketosis via oral ketone ester supplementation on physical and mental recovery during a multi-day cycling stage race.

Detailed Description

Ultra-endurance events are becoming increasing popular. Participation in the multi-day events adds a lot of physical and mental strain on the body, while the athletes are still required to perform. Without appropriate recovery the athletes are at increased risk of overreaching, injury, or illness.

Therefore, the purpose of the study is to create a better understanding of the exercise fatigue experienced during ultra-endurance performance and the role intermittent exogenous ketosis (IEK) plays in reducing the amount of fatigue to maintain performance during multi-day racing and lower the risk of injury and illness.

Participants will first compete in a 8-day simulated stage race performed on taxc trainers and then we will conduct a field study during the Absa Cape Epic a 8-day mountain bike stage race. Immediately following each stage and 30-mins before bed the participants will consume either a ketone ester and taste-match placebo drink. During the race the following variables will be measured; hydration status, weight change, activity readiness, and nutrition intake. Cognitive function will be assessed on day 2, 4 and 8 of racing. One day before and one day after the race the participants will report to the lab to assess basal metabolic rate, stress via questionnaires, appetite, cognitive function, muscle biopsies, venous blood samples, mechanical efficiency and 30-min Time Trial.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
24
Inclusion Criteria
  • have been cycling consistently for at least 1 year before entry into the study
  • have been cycling for a minimum of 7 hours per week for the 6 months leading up to the study
  • additional for the field study: valid entry to the 2025 edition of the Absa Cape Epic
  • non-smoker
Exclusion Criteria
  • Do not follow a ketogenic diet or low-carbohydrate diet
  • Have any metabolic or auto-immune disease that will influence their metabolism
  • Take medication or supplements that is known to affect ketone supplement metabolism
  • suffering from a recurring injury or illness from which they have not fully recovered that is a contr-indication to perform high-intensity exercise
  • Unable to finish each stage
  • Women: if they are pregnant or breastfeeding

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Muscle sorenessDuring the intervention

Visual analog scale (0-10) How sore does you leg muscles feel? The VAS was used as a subjective measure of muscle soreness

Sleep: Non-REM1 week prior to racing and during the race

The Fitbit Inspire 3 will be used to determine the NON-REM sleep phase for each night in minutes

Sleep: WASO1 week prior to racing and during the race

The FITBIT inspire 3 will be used to measure wake after sleep onset in minutes for each night

Hydration statusBaseline, During the intervention and 1 day after the intervention

Before every stage, the participants provided a urine sample in a cup. A urine-specific refractometer (Atago) was used to determine their hydration status

Cognitive function: reaction timePre-intervention, day 2, 4 and 8 of the intervention

CANTAB test battery reaction time test was used to determine reaction time in milliseconds.

Cognitive function: rapid visual processingPre-intervention, day 2, 4 and 8 of the intervention

CANTAB test battery rapid visual processing test was used to assess their susceptibility to false alarms

Cognitive function: swmPre-intervention, day 2, 4 and 8 of the intervention

CANTAB spatial working memory test was used to access executive function; the main outcome measure used was the number of errors

Sleep: REM1 week prior to racing and during the race

The Fitbit Inspire 3 was used to measure the total duration of rapid eye motion (REM)sleep during each night for the duration of the study. The REM sleep phase will be analysed in minutes

Physical stresspre-intervention and 1 day after the intervention

RESTQ-76 sport questionnaire was used to assess the stress-recovery balance

Sleep Duration1 week prior to racing and during the race

Fitbit inspire 3 was used to measure sleep duration (hours:minutes:seconds)

Secondary Outcome Measures
NameTimeMethod
Mechanical efficiencypre-intervention and 1 day after the intervention

Mechanical efficiency will be determined during three constant load (100 watts, 150 watts, and 200 watts) cycling bouts of 5 minutes on a calibrated ergometer (Avantronic Cyclus II). Throughout the test, gas exchange will continuously be measured using calibrated metabolic analyzer with a face mask (Cortex, Metalyzer IIIb). VO2 and VCO2 data of the final minute of each workload will be used to calculate gross efficiency (%).

Time trial performancepre-intervention and 1 day after the intervention

The participants will perform a 30-minute time trial. The average power output (watts) achieved will be used as the outcome measure.

Appetitepre-intervention, during the intervention, 1 day after the intervention

Appetite will be assessed with a Likert visual analog scale (0-10) using the following four questions:

"How hungry do you feel?" "How full do you feel?" "How satisfied do you feel?" "How much do you think you could eat now?"

Macronutrient intakebaseline, during the intervention

Participants will complete a food diary using the Mijnetemeter application on their phone. Total fat, protein and carbohydrate intake will be determined in grams for each day.

Total energy intakebaseline, during the intervention

Participants will complete a food diary, using the Mijnetemeter application on their phones. total energy intake (kilojoules) will be calculated for each day.

Racing intensityduring each stage

hear rate zones during racing

Body weight changeDuring the intervention

Body mass was measured using a SECA, model 813 electrical scale, before and after each stage as a secondary method to assess hydration status. Body mass was measured to the nearest 0.1 kilogram

Trial Locations

Locations (1)

KU Leuven

🇧🇪

Leuven, Vlaams-Brabant, Belgium

KU Leuven
🇧🇪Leuven, Vlaams-Brabant, Belgium
Monique Ramaekers
Contact
+32 16 32 90 92
monique.ramaekers@kuleuven.be

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.